Qualifying Therapeutic Discovery Project Grants for the State of Alabama
The listings below represent the applicants that have been awarded a Qualifying Therapeutic Discovery Program Grant.
The project descriptions below were extracted from the applicant certification forms as submitted.
| Applicant Name | Project Name | Grants Awarded for 2009 | Grants Awarded for 2010 |
|---|---|---|---|
| Agenta Biotechnologies Inc | Molecular Heparan Sulfate Delivery in Barrier Membranes and Soft Tissue Wound Closure | $ 59,614.76 | $ 184,864.48 |
| AGENTA BIOTECHNOLOGIES INC | DELIVERY OF GROWTH-FACTOR CO-RECEPTOR HEPARAN SULFATE IN BONE GRAFT SUBSTITUTES FOR REPAIR | $ 169,808.39 | $ 6,666.50 |
| BioCryst Pharmaceuticals Inc | BCX4208 for Treatment of Gout | $ 244,479.25 | |
| BioCryst Pharmaceuticals, Inc | Peramivir for Treatment of Influenza | $ 244,479.25 | |
| BioCryst Pharmaceuticals, Inc | Forodesine for Treatment of CLL and CTCL | $ 244,479.25 | |
| BioCryst Pharmaceuticals, Inc. | BCX4161 for Treatment of Hereditary Angioedema | $ 86,380.89 | |
| BioCryst Pharmceuticals, Inc. | JAK Inhibitors for Treatment of Psoriasis, Ankylosing Spondylitis, & Multiple Sclerosis | $ 244,479.25 | |
| Diatherix Laboratories, Inc. | Disease Diagnostic Panel Development Utilizing the TEM-PCR Method | $ 244,479.25 | |
| EGEN INC | EGEN-001 in Platinum-Resistant Ovarian Cancer | $ 244,479.25 | |
| EGEN, INC. | EGEN TheraSilence | $ 244,479.25 | |
| iCubate, Inc | Development of an Apparatus for Performing am-PCR | $ 244,479.25 | |
| PNP Therapeutics Inc | Phase 1, Open-label Syudy Evaluting the Safety of Escalating Doses of Ad/PNP-F-araAMP | $ 244,479.25 | |
| Serina Therapeutics, Inc | SER-201 for the treatment of colorectal and ovarian cancer | $ 244,479.25 | |
| Vaxin Inc. | Development of an Adenovirus-Vectored Nasal Anthrax Vaccine | $ 244,479.25 | |
| Vaxin Inc. | Replication-Defective Adenovirus-Vectored Influenza Vaccine Development | $ 161,175.00 | $ 83,304.25 |
| Vista Engineering Inc | Nanotechnology Enabled Temporomandibular Joint (TMJ) Prosthesis | $ 29,059.63 | $ 32,059.00 |
| Volatile Analysis Corporation | Development of sorptive nasal stent for diagnostic biomarker detection | $ 23,600.00 | $ 182,500.00 |
References/Related Topics
Page Last Reviewed or Updated: 2012-10-12
